arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

SHOULDER INNOVATIONS, INC.

SI
$20.55 ▼ -1.98 (-8.81%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
10 Visible periods
28 Metrics
Peer-ranked Benchmarks
Price Chart
30
Health
Poor
Bearish
auto_awesome

Analytical Summary

SHOULDER INNOVATIONS, INC. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $424.4M
Dividend Yield
Revenue Growth 64.9%
Op. Margin -53.7%
ROIC -6.1%
FCF / Share $-0.73
Trailing P/E
Price / Book 3.2x
FCF Yield
Debt / Equity 0.11
info Valuation on last close. End-of-day price, Aug 7, 2026.

10-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$16.71M
↑ +64.9%
Net Income Profit after all expenses
$-8.38M
↓ -79.7%
Operating Margin Operating profit as % of sales
-53.7%
↑ +8.9% 5th
FCF / Share Free cash flow per share
$-0.73
↑ +12.6%
Long-Term Debt Long-term obligations
$14.96M
— +0.3%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
4
Returns
24
Financial Health
54
Cash Quality
60

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 3 years · 10 quarters